Physician profile
Timothy Allen
NPI 1417945932
$74,336.98
in general payments reported to CMS, 2019-2025
12 companies · $373 in 2025
The $373 reported for 2025 was more than what 85% of Anatomic Pathology & Clinical Pathology providers received nationally (typical 2025 total: $50.59).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $22K · 2021: $14K · 2022: $10K · 2023: $9,555 · 2024: $2,425 · 2025: $373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,750 · Consulting Fee: $3,938 · Travel and Lodging: $1,519 · Food and Beverage: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,750.00 |
| Consulting Fee | $3,937.50 |
| Travel and Lodging | $1,519.34 |
| Food and Beverage | $146.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $32,291.25 | 2020-2025 | |
| Pfizer INC. | $21,342.85 | 2020-2023 | |
| Merck Sharp & Dohme LLC | $13,088.74 | 2019-2023 | Keytruda |
| E.R. Squibb & Sons, L.L.C. | $4,711.24 | 2019 | |
| Roche Diagnostics Corporation | $2,425.00 | 2024 | |
| Genentech USA, INC. | $235.78 | 2019-2022 | |
| Emd Serono, INC. | $94.38 | 2022 | |
| Dermavant Sciences, INC. | $41.30 | 2023 | Vtama |
| Caris Mpi, INC. | $37.13 | 2025 | Mi Cancer Seek |
| Janssen Scientific Affairs, LLC | $35.61 | 2020 | |
| Organon LLC | $18.84 | 2025 | Vtama |
| Botanix Sb INC | $14.86 | 2025 | Sofdra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.